Source: Eur Respir J, 56 (3) 2002773; 10.1183/13993003.02773-2020
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Amy Sarah Ginsburg, Keith P. Klugman. Antibiotics for paediatric community-acquired pneumonia in resource-constrained settings. Eur Respir J, 56 (3) 2002773; 10.1183/13993003.02773-2020

Member's Comments

No comment yet.

Related content which might interest you: Antibiotic management of nosocomial pneumonia in children Source: Eur Respir J 2006; 28: Suppl. 50, 633s Year: 2006 Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia Source: Eur Respir J 2006; 27: 1210-1216 Year: 2006 Particularities of community-acquired pneumonia in the elderly Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections Year: 2007 Corticosteroids and community-acquired pneumonia Source: Annual Congress 2007 - Corticosteroids and respiratory failure Year: 2007 Can the broad-spectrum antibiotics improve the prognoses of high-risk nursing- and healthcare-associated pneumonia? Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia Source: ERS Course 2018 - Respiratory Infections Year: 2018 Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 The cost of inpatient care in community-acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 258s Year: 2005 Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens Source: Eur Respir J 2002; 20: 432-439 Year: 2002 Outpatient treatment of community-acquired pneumonia in the elderly Source: Eur Respir J 2002; 20: Suppl. 38, 355s Year: 2002 Weight of CURB-65 criteria for community-acquired pneumonia in a very low-mortality-rate setting Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Antibiotic therapy of community-acquired pneumonia in the hospital setting: national guidelines and real clinical practice. Source: International Congress 2017 – COPD management Year: 2017 Optimizing treatment for community-acquired pneumonia through a care bundle Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Promising prophylactic means and methods for prevention of community-acquired pneumonia and respiratory infections among servicemen in Russia Source: Eur Respir J 2006; 28: Suppl. 50, 350s Year: 2006 Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Broad-spectrum antibiotics cannot improve the prognoses of high-risk nursing- and healthcare-associated pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 The etiological agents of community-acquired pneumonia in our hospital Source: Eur Respir J 2006; 28: Suppl. 50, 735s Year: 2006 The impact of 2016 guideline on clinical practice for the management of hospital-acquired and ventilator-associated pneumonia in Taiwan Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Nosocomial pneumonia in oncology Source: Eur Respir J 2004; 24: Suppl. 48, 412s Year: 2004